Skip to main content
. 2020 May 18;17(9):1257–1268. doi: 10.7150/ijms.44285

Figure 1.

Figure 1

Increased expression levels of IL-1β were correlated with advanced tumor stage in HNSCC and melanoma patients. IL-1β concentrations were detected using ELISA assay. (A) The concentrations of IL-1β in HNSCC patients and healthy donors (HD) were compared. (B) The correlation between IL-1β and tumor stage of HNSCC patients was assessed. (C) The concentrations of IL-1β in melanoma patients and healthy donors were compared. (B) The correlation between IL-1β and tumor stage of melanoma patients was assessed.